Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 19, 2013
ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic originAbbas Agaimy, Katharina Erlenbach-Wünsch, Björn Konukiewitz, et al.
The American Journal of Gastroenterology|July 2, 2009
Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patientsLuca Frulloni, Chiara Scattolini, Massimo Falconi, et al.
Pancreas|April 1, 2014
Retrospective comparison between preoperative diagnosis by International Consensus Diagnostic Criteria and histological diagnosis in patients with focal autoimmune pancreatitis who underwent surgery with suspicion of cancerTsukasa Ikeura, Sönke Detlefsen, Giuseppe Zamboni, et al.
Scientific Reports|December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumorsMauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 1, 2006
Intraductal papillary mucinous neoplasms and chronic pancreatitisGiorgio Talamini, Giuseppe Zamboni, Roberto Salvia, et al.
United European Gastroenterology Journal|June 12, 2014
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitisTsukasa Ikeura, Riccardo Manfredi, Giuseppe Zamboni, et al.
Surgery|December 30, 2017
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasmsStefano Partelli, Emilio Bertani, Mirco Bartolomei, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomasGiuseppe S Bogina, Gianluigi Lunardi, Lisa Marcolini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20Björn Konukiewitz, Anna Melissa Schlitter, Moritz Jesinghaus, et al.
Pituitary|August 3, 2021
Pituitary metastases from neuroendocrine neoplasms: case report and narrative reviewAlberto Ragni, Alice Nervo, Mauro Papotti, et al.
Pageof 15